← All Viridian Therapeutics, Inc\de filings

Viridian Therapeutics, Inc\de Schedule 13D activist filings

Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.

NASDAQ
VRDN
Viridian Therapeutics, Inc\de
SCHEDULE: Fairmount Funds Management Boosts Viridian Therapeutics Stake
Fairmount Funds Management LLC and its affiliate have increased their beneficial ownership in Viridian Therapeutics, Inc. to 14.04% following a recent public offering.
NASDAQ
VRDN
Viridian Therapeutics, Inc\de
SCHEDULE: Fairmount Boosts Viridian Therapeutics Stake to 15.14%
Fairmount Funds Management LLC and Fairmount Healthcare Fund II GP LLC increased their beneficial ownership in Viridian Therapeutics, Inc. to 15.14% through a recent public offering.